Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine in PTSD (Japanese Patients)
NCT00557622Phase 2Terminated
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paroxetine in post-traumatic stress disorder (PTSD), sponsored by GSK. Started Jan 2008; status: terminated.
02
Drugs
paroxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00557622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557622.